7733.T
Olympus Corporation

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2026-03-31

Average Intrinsic Value

7.08B USD

Market Cap

11.66B USD

Margin of Safety

-64.8%

Intrinsic / Market Ratio

0.61×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

10.78B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

5.51B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

4.94B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

7.08B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

7.08B USD

from the sum above

Market Cap

11.66B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.61×

the ratio the screener ranks by; Margin of Safety -64.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 10.78B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)11.23B USD
−②Net Debt Today449.81M USD
+③Growth Value0 USD
=Value10.78B USD

EPV of the Operations (NOPAT over WACC)

11.23B USD

Net debt today

-449.81M USD

Growth Value

0 USD

Value

10.78B USD

①EPV (earnings power value)

11.23B USD

②Net Debt Today

449.81M USD

③Growth Value

0 USD

Market value

Market Cap11.66B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-8.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 5.51B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE3.82B USD
+②Equity at Year 15, Today1.70B USD
=Value5.51B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

3.82B USD

②Equity at Year 15, Today

1.70B USD

Market value

Market Cap11.66B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-111.6%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 4.94B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 4.94B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Debt Today

Not in the value

Market value

Market Cap11.66B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-136.0%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 5.64%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.26×Market Risk Premium 6.00%= 6.04%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 161.71M USDPretax Income 588.63M USD= 27.47%

The tax the interest saves.

Interest Expense =EBIT 646.86M USD−Pretax Income 588.63M USD= 58.22M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 58.22M USDTotal Debt 1.58B USD×(1 − Tax Rate for WACC 27.47%)= 2.68%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 1.58B USDMarket Cap + Total Debt 11.66B USD + 1.58B USD= 11.90%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 88.10%×Cost of Equity 6.04%+Debt Weight 11.90%×Cost of Debt 2.68%= 5.64%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2025-09-30.

Total Assets 9.33B USD − Total Liabilities 4.39B USD = Book Value Today 4.94B USD

Total Debt 1.58B USD − Cash and Short-Term Investments 1.13B USD = Net Debt Today 449.81M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-5.0%at most 5%passes1,107,931,728 / 1,165,631,793
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.2%at least -10.0%passes(629.91M USD − 426.93M USD) ÷ 9.33B USD
Price to bookMarket Cap ÷ Book Value Today2.36×at most 3×passes11.66B USD ÷ 4.94B USD
Operating marginOperating Income ÷ Revenue10.0%above 10.0%does not pass631.38M USD ÷ 6.33B USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-5.1%above 10.0%does not pass6.33B USD / 6.67B USD
Net cash(Cash − Total Debt) ÷ Market Cap-5.0%above -30%passes(991.86M USD − 1.58B USD) ÷ 11.66B USD
Operating efficiencyOperating Income ÷ Gross Profit15.4%above 25.0%does not pass631.38M USD ÷ 4.10B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

1720.72 JPY

Enterprise value

2.03T JPY

the provider's own figure

EV / EBITDA

9.27×

Price / book

2.44×

the provider's book

Price / earnings

28.09×

Return on equity

10.6%

the provider's figure, not this page's

Profit margin

7.5%

Revenue growth

16.4%

Analyst target, mean

2086.70 JPY

Analysts

13

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2023202420252026
Income statement

Revenue

6.63B6.12B6.67B6.33B

Gross profit

4.49B4.09B4.57B4.10B

Operating income

1.40B342.03M1.08B631.38M

EBITDA

operating income before depreciation and amortisation

1.93B792.17M1.55B1.07B

Pretax income

1.37B288.26M1.06B588.63M

Net income

1.08B1.60B788.50M426.93M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

1.04B229.38M788.13M426.93M

R&D

————
Balance sheet, year end

Total assets

11.34B10.14B9.59B9.63B

Total liabilities

6.52B5.14B4.56B4.54B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

4.81B5.00B5.03B5.09B

Total debt

2.56B1.98B1.53B1.50B

Cash and equivalents

1.27B2.25B1.69B1.18B

Net PP&E

fixed assets after depreciation

1.79B1.72B1.76B1.80B

Working capital

current assets less current liabilities

1.99B2.44B1.70B1.69B
Cash flow

Operating cash flow

740.15M280.03M1.27B629.91M

Capital expenditure

paid out, so below zero

-530.73M-427.16M-436.28M-516.17M

Depreciation and amortisation

501.56M435.86M444.62M420.94M

Free cash flow

operating cash flow plus capital expenditure

209.42M-147.13M838.00M113.74M